Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Henk Bekedam appointed new WHO representative to India
Senior public health specialist Henk Bekedam has taken charge as the World Health Organisation representative to India, an official statement.

[adsense:336x280:8701650588]
- Read more about Losing one gram fat from pancreas can reverse diabetes
Researchers have shown that Type-2 diabetes is caused by fat accumulating in the pancreas and that losing less than one gram of that fat through weight loss reverses the condition.
- Read more about Almonds healthier than earlier believed, say experts
Almonds contain 20 percent lower calories than originally believed, claims a study released.
- Read more about Novel therapy could cut hepatitis C prevalence by 80 percent
Recently approved antiviral medications for hepatitis C could reduce the prevalence of the blood-borne infection by more than 80 percent, researchers have estimated.
- Read more about AIDS programme to continue as central scheme: Nadda
Health Minister J.P. Nadda on Tuesday announced that the National AIDS Control Programme will continue as a central sector scheme, following concerns over the ability of some states on contributing their share to the programme.
- Read more about Homely remedies to tackle Psoriasis
Psoriasis, a chronic inflammatory skin disease, can be easily deal with by homegrown solutions.
- Read more about Asthma may lead to chronic migraine
Pre-existing asthma may be a strong predictor of future chronic migraine attacks in individuals experiencing occasional migraine headaches, according to researchers from the University of Cincinnati (UC) in the US.
- Read more about Roche and Upsher-Smith joined to develop novel VAP-1 Inhibitor
Upsher-Smith Laboratories, Inc. (Upsher-Smith), through its wholly-owned UK subsidiary Proximagen Ltd. joined with Roche for the further development of a novel, oral small molecule inhibitor of Vascular Adhesion Protein 1 (VAP-1), a cell-adhesion molecule that may be effective in the treatment of inflammatory diseases. The VAP-1 inhibitor is currently in phase II clinical development.
- Read more about BMS Foundation marks World AIDS Day with Grants Totaling More than $3.5M for HIV and Cervical and Breast Cancer programs in Africa
To mark World AIDS Day, the Bristol-Myers Squibb Foundation today announced 16 grants totaling $3.5 million for programs in Africa that strengthen HIV services for adolescents and the elderly, raise awareness and access to health care for women co-diagnosed with HIV and breast or cervical cancer, and build community capacity and integrate treatment for HIV/tuberculosis (TB) co-infection.
- Read more about Janssen submits applications seeking approval of STELARA® in US and EU for Crohn’s Disease
Janssen Biotech, Inc. and Janssen-Cilag International NV (Janssen) announced today the submission of a Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) and a Grouped Type II Variation/Extension Application to the European Medicines Agency (EMA) seeking approval of STELARA® (ustekinumab) for the treatment of adult patients with moderately to severely active Crohn’s disease. Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract that affects approximately 700,000 Americans1 and nearly 250,000 Europeans.2